{"id":{"repo_id":"calgary","oai_identifier":"oai:ucalgary.scholaris.ca:1880/119045"},"canonical_url":"https://search.dev.ndltd.org/etd/calgary/oai:ucalgary.scholaris.ca:1880/119045","repository":{"repo_id":"calgary","name":"University of Calgary","base_url":"https://ucalgary.scholaris.ca/server/oai/request"},"display":{"title":"Pericyte deficiencies in a foxf2 loss of function mutant","abstract":"Pericytes are critical players in vascular development and disease but are not widely studied in the context of cerebral small vessel disease, a vascular condition related to stroke that progressively weakens brain microvessels. Foxf2, a pericyte-expressed gene, is involved in vascular stability and reduced FOXF2 is associated with increased stroke risk and CSVD prevalence. Here, I use a zebrafish foxf2a loss of function mutant as a genetic model of CSVD to show pathological alterations in brain pericytes. Not only are there fewer brain pericytes across the lifespan, but these pericytes also exhibit morphological abnormalities like increased soma size, process length and degeneration. These abnormalities manifest differently in adult brains, and blood vessel defects are evident. I show that embryonic pericyte defects are not the result of decreased pericyte density but a combination of cell-autonomous and non-cell-autonomous effects. A downstream target of foxf2a, loxl2b, is downregulated in foxf2 mutants. While loxl2b mRNA is sufficient to boost brain pericyte numbers, mutants for this gene do not show an obvious phenotype, suggesting a more complicated role. This thesis sheds light on novel lifespan defects in mutant brain pericytes, potentially contributing to vascular destabilization, and opens new avenues for studying genetic forms of human cerebral small vessel disease.","abstract_html":"Pericytes are critical players in vascular development and disease but are not widely studied in the context of cerebral small vessel disease, a vascular condition related to stroke that progressively weakens brain microvessels. Foxf2, a pericyte-expressed gene, is involved in vascular stability and reduced FOXF2 is associated with increased stroke risk and CSVD prevalence. Here, I use a zebrafish foxf2a loss of function mutant as a genetic model of CSVD to show pathological alterations in brain pericytes. Not only are there fewer brain pericytes across the lifespan, but these pericytes also exhibit morphological abnormalities like increased soma size, process length and degeneration. These abnormalities manifest differently in adult brains, and blood vessel defects are evident. I show that embryonic pericyte defects are not the result of decreased pericyte density but a combination of cell-autonomous and non-cell-autonomous effects. A downstream target of foxf2a, loxl2b, is downregulated in foxf2 mutants. While loxl2b mRNA is sufficient to boost brain pericyte numbers, mutants for this gene do not show an obvious phenotype, suggesting a more complicated role. This thesis sheds light on novel lifespan defects in mutant brain pericytes, potentially contributing to vascular destabilization, and opens new avenues for studying genetic forms of human cerebral small vessel disease.","abstract_has_math":false,"creators":["Graff, Merry Faye"],"institution":"Graduate Studies","degree_name":"Master of Science (MSc)","degree_level":null,"degree_discipline":"Medicine – Biochemistry and Molecular Biology","degree_department":null,"school":null,"contributors":[],"advisors":["Childs, Sarah"],"committee_chairs":[],"committee_members":["McFarlane, Sarah","Grewal, Savraj"],"year":2024,"date_issued":"2024-06-26","date_published":"2024-06-26","updated_at":"2026-07-24T01:30:25Z","subjects":["Pericytes","Vascular Stability","Foxf2","Zebrafish","Loxl2","Endothelium","Cerebral Small Vessel Disease","Development"],"languages":["en"],"rights":["University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission."],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.11575/PRISM/46641"],"render_values":[{"text":"https://doi.org/10.11575/PRISM/46641","href":"https://doi.org/10.11575/PRISM/46641","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/1880/119045","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Childs, Sarah"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["McFarlane, Sarah","Grewal, Savraj"]},{"key":"dc:creator","label":"Author","values":["Graff, Merry Faye"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2027-05"]},{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-06-27T18:49:32Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2024-06-27T18:49:32Z"]},{"key":"dc:date.issued","label":"Date","values":["2024-06-26"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Calgary"]},{"key":"dc:type","label":"Dc Type","values":["master thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medicine – Biochemistry and Molecular Biology"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MSc)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Calgary"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Pericytes","Vascular Stability","Foxf2","Zebrafish","Loxl2","Endothelium","Cerebral Small Vessel Disease","Development"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.11575/PRISM/46641"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1880/119045"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Pericytes are critical players in vascular development and disease but are not widely studied in the context of cerebral small vessel disease, a vascular condition related to stroke that progressively weakens brain microvessels. Foxf2, a pericyte-expressed gene, is involved in vascular stability and reduced FOXF2 is associated with increased stroke risk and CSVD prevalence. Here, I use a zebrafish foxf2a loss of function mutant as a genetic model of CSVD to show pathological alterations in brain pericytes. Not only are there fewer brain pericytes across the lifespan, but these pericytes also exhibit morphological abnormalities like increased soma size, process length and degeneration. These abnormalities manifest differently in adult brains, and blood vessel defects are evident. I show that embryonic pericyte defects are not the result of decreased pericyte density but a combination of cell-autonomous and non-cell-autonomous effects. A downstream target of foxf2a, loxl2b, is downregulated in foxf2 mutants. While loxl2b mRNA is sufficient to boost brain pericyte numbers, mutants for this gene do not show an obvious phenotype, suggesting a more complicated role. This thesis sheds light on novel lifespan defects in mutant brain pericytes, potentially contributing to vascular destabilization, and opens new avenues for studying genetic forms of human cerebral small vessel disease."]},{"key":"dc:title","label":"Title","values":["Pericyte deficiencies in a foxf2 loss of function mutant"]}]}],"canonical_facts":{"dc:contributor.advisor":["Childs, Sarah"],"dc:contributor.committeemember":["McFarlane, Sarah","Grewal, Savraj"],"dc:creator":["Graff, Merry Faye"],"dc:date":["2027-05"],"dc:date.accessioned":["2024-06-27T18:49:32Z"],"dc:date.available":["2024-06-27T18:49:32Z"],"dc:date.issued":["2024-06-26"],"dc:description.abstract":["Pericytes are critical players in vascular development and disease but are not widely studied in the context of cerebral small vessel disease, a vascular condition related to stroke that progressively weakens brain microvessels. Foxf2, a pericyte-expressed gene, is involved in vascular stability and reduced FOXF2 is associated with increased stroke risk and CSVD prevalence. Here, I use a zebrafish foxf2a loss of function mutant as a genetic model of CSVD to show pathological alterations in brain pericytes. Not only are there fewer brain pericytes across the lifespan, but these pericytes also exhibit morphological abnormalities like increased soma size, process length and degeneration. These abnormalities manifest differently in adult brains, and blood vessel defects are evident. I show that embryonic pericyte defects are not the result of decreased pericyte density but a combination of cell-autonomous and non-cell-autonomous effects. A downstream target of foxf2a, loxl2b, is downregulated in foxf2 mutants. While loxl2b mRNA is sufficient to boost brain pericyte numbers, mutants for this gene do not show an obvious phenotype, suggesting a more complicated role. This thesis sheds light on novel lifespan defects in mutant brain pericytes, potentially contributing to vascular destabilization, and opens new avenues for studying genetic forms of human cerebral small vessel disease."],"dc:identifier.doi":["https://doi.org/10.11575/PRISM/46641"],"dc:identifier.uri":["https://hdl.handle.net/1880/119045"],"dc:language.iso":["en"],"dc:publisher.institution":["University of Calgary"],"dc:rights":["University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission."],"dc:subject":["Pericytes","Vascular Stability","Foxf2","Zebrafish","Loxl2","Endothelium","Cerebral Small Vessel Disease","Development"],"dc:title":["Pericyte deficiencies in a foxf2 loss of function mutant"],"dc:type":["master thesis"],"thesis:degree_discipline":["Medicine – Biochemistry and Molecular Biology"],"thesis:degree_name":["Master of Science (MSc)"],"thesis:institution_name":["University of Calgary"]},"updated_at":"2026-07-24T01:30:25Z"}